All In Biotech

Drug Trial Radar · NCT00809146

Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications

A Double-blind Randomized Clinical Trial of the Efficacy of IM Midazolam Versus IV Lorazepam in the Pre-hospital Treatment of Status Epilepticus by Paramedics

Last checked: Nov 19, 2026Latest source record: Jun 17, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,023 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,023

Actual

Start

Jun 2009

Primary completion

Jan 2011

Study completion Jan 2011

Sponsor

Lead sponsor
Robert SilbergleitAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Medical University of South Carolina; University of California, San Francisco; National Institute of Neurological Disorders and Stroke (NINDS)
First posted
Dec 17, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.

Conditions

  • Status Epilepticus

Interventions

  • Intramuscular route of active treatmentDrug

    IM administration by autoinjector of midazolam 5 mg for subjects under estimated weight of 40 kg or midazolam 10 mg for subjects with estimated weight of 40 kg or above, IV administration of matching volume of IV flush.

  • Intravenous route of active treatmentDrug

    IV administration of lorazepam 2 mg for subjects under estimated weight of 40 kg or midazolam 4 mg for subjects with estimated weight of 40 kg or above, IM administration by autoinjector of matching volume of saline.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Subjects With Termination of Seizures at ED Arrival With no Rescue Therapy GivenTime frame: Duration of prehospital care, outcome is determined upon arrival at the ED on the day of enrollment (average 20 minutes).

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • University of Arizona

    Tucson, Arizona

  • Stanford University

    Palo Alto, California

  • University of California-San Francisco

    San Francisco, California

  • Emory University

    Atlanta, Georgia

  • University of Kentucky

    Lexington, Kentucky

  • University of Maryland

    Baltimore, Maryland

  • Henry Ford Health System

    Detroit, Michigan

  • Wayne State University

    Detroit, Michigan

  • University of Minnesota

    Minneapolis, Minnesota

  • New York Presbyterian Hospital

    New York, New York

  • University of Cincinnati Medical Center

    Cincinnati, Ohio

  • Oregon Health and Science University

    Portland, Oregon

  • University of Pennsylvania/York

    Philadelphia, Pennsylvania

  • Temple University-Main Line

    Philadelphia, Pennsylvania

  • University of Texas-Houston

    Houston, Texas

  • Virginia Commonwealth University

    Richmond, Virginia

  • Medical College of Wisconsin

    Milwaukee, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.